Trial Participation Decision Making in Ovarian Cancer Patients and Their Families

Project: Research project

Project Details

Description

DESCRIPTION (provided by applicant): Ovarian cancer is characterized as the most lethal gynecologic cancer and mortality due to this disease has not changed in over 50 years. Several novel therapies against ovarian cancer are in development at Mayo Clinic (MC) and elsewhere. Ultimately, the availability of new agents against this cancer requires patients to enroll in clinial trials in sufficient numbers, yet,
StatusFinished
Effective start/end date1/1/1412/31/15

Funding

  • National Institutes of Health: $79,500.00
  • National Institutes of Health: $79,500.00

ASJC

  • Medicine(all)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.